Shenzhen Jiechuang Trading
Ordered peptides from Shenzhen Jiechuang Trading? Mail in a sample (US only) and let us test it.
Test my supplyShenzhen Jiechuang Trading's strongest purity-focus evidence is Retatrutide, with recent identity passes, 99.7–99.95% purity, and modest fill variance. Tirzepatide is dispersed and recently worse, including a 97.93% purity miss and 0 mg identity failure after earlier passes, while missing batch IDs limit traceability.
We investigated who actually operates Shenzhen Jiechuang Trading — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Shenzhen Jiechuang Trading rows.
Cancel anytime
Ordered peptides from Shenzhen Jiechuang Trading? Mail in a sample (US only) and let us test it.
Test my supply| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
19 Sep 2026 | Pass | Tirzepatide Shenzhen Jiechuang Trading | lab name | View COA | |||
6 Aug 2026 | Fail | Tesamorelin Shenzhen Jiechuang Trading | lab name | View COA | |||
3 Aug 2026 | Pass | Retatrutide Shenzhen Jiechuang Trading | lab name | View COA | |||
20 Jul 2026 | Pass | Tirzepatide Shenzhen Jiechuang Trading | lab name | View COA | |||
5 Jun 2026 | Incomplete | Tesamorelin Shenzhen Jiechuang Trading | lab name | View COA | |||
4 Jun 2026 | Pass | Tesamorelin Shenzhen Jiechuang Trading | lab name | View COA | |||
4 Mar 2026 | Fail | Tirzepatide Shenzhen Jiechuang Trading | lab name | View COA | |||
26 Feb 2026 | Pass | Retatrutide Shenzhen Jiechuang Trading | lab name | View COA | |||
26 Feb 2026 | Fail | Tirzepatide Shenzhen Jiechuang Trading | lab name | View COA | |||
26 Feb 2026 | Pass | Tesamorelin Shenzhen Jiechuang Trading | lab name | View COA | |||
About Shenzhen Jiechuang Trading test results from Finnrick
Shenzhen Jiechuang Trading is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 3 peptides and 19 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Shenzhen Jiechuang Trading peptides in this dataset are Retatrutide (5 tests), Tesamorelin (4 tests) and Tirzepatide (10 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 19 recent tests.
Ordered peptides from Shenzhen Jiechuang Trading? Mail in a sample (US only) and let us test it.
Test my supply